|
|
|
|
|
|
|
Product Classification : API
NO. |
English Name |
CAS NO. |
Specification |
Order |
1 |
Acitretin |
55079-83-9 |
EP/BP/USP |
Order |
2 |
Adenine |
73-24-5 |
USP |
Order |
3 |
Ambroxol Hydrochloride |
23828-92-4 |
EP |
Order |
4 |
Azithromycin |
83905-01-5 |
USP |
Order |
5 |
Brimonidine Tartrate |
70359-46-5 |
EP |
Order |
6 |
Diphenhydramine hydrochloride |
147-24-0/8052-21-9 |
99% |
Order |
7 |
Diphenhydramine Hydrochloride |
147-24-0 |
EP7.0/BP2010/USP33 |
Order |
8 |
Donepezil hydrochloride |
120011-70-3 |
|
Order |
9 |
Dapoxetine hydrochloride |
129938-20-1 |
98% |
Order |
10 |
Drospirenone |
67392-87-4 |
USP |
Order |
11 |
Diosmin |
520-27-4 |
EP |
Order |
12 |
Epinastine Hydrochloride |
80012-44-8 |
99% |
Order |
13 |
Epinastine |
80012-43-7 |
99% |
Order |
14 |
Eplerenone |
107724-20-9 |
99% |
Order |
15 |
Gestodene |
60282-87-3 |
99% |
Order |
16 |
Isotretinoin |
4759-48-2 |
USP |
Order |
17 |
Metoclopramide |
364-62-5 |
CP2010 |
Order |
18 |
Methyl 4-acetamido-5-chloro-2-methoxybenzoate |
4093-31-6 |
In-house Standard |
Order |
19 |
Metoclopramide Hydrochloride |
54143-57-6 |
EP7.0/BP2010 |
Order |
20 |
Sodium Aminosalicylate |
6018-19-5 |
EP7.0/BP2010 |
Order |
21 |
Simvastatin |
79902-63-9 |
USP |
Order |
22 |
Sodium4-aminosalicylate |
133-10-8 |
USP |
Order |
23 |
Tretinion |
302-79-4 |
USP |
Order |
24 |
Triamcinolone Acetonide |
76-25-5 |
USP |
Order |
Product Classification : Medicine Intermediates
NO. |
Product Name |
CAS No. |
Specification |
Order |
1 |
Acitretin butyl ester |
54757-45-8 |
98% |
Order |
2 |
Epinastine hydrobromide |
127786-29-2 |
99% |
Order |
3 |
6-(Aminomethyl)-6,11-dihydro-5H-dibenz(b.e) azpine succinate |
|
98% |
Order |
4 |
(3β,5β,15α,16α)-15,16-Dihydro-3,5-dihydroxy-3'H-cycloprop[15,16]androsta-6,15-dien-17-one |
82543-15-5 |
98% |
Order |
5 |
3β,5-Dihydroxy-6β,7β:15β,16β-dimethylene-5β-androstan-17-one |
82543-16-6 |
98% |
Order |
6 |
5-(4-methoxy-2,3,6-trimethylphenyl)-3-methyl-2,4-pentadienyl-1-Triphyl phosphonphonium bromide |
62285-98-7 |
98% |
Order |
|
|
|
|
|
|
|
|